Pancreatic Cancer Research

ResearcherXiamen UniversityNo recent work listed

Binbin Wei

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes. Co-author DOI 10.1002/ijc.34208↗
  2. Chemotherapeutic efficacy of cucurmosin for pancreatic cancer as an alternative of gemcitabine: a comparative metabolomic study. Co-author DOI 10.21037/gs-20-202↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tianhong Teng · 2 shared papers, 2020–2022 · strength 0.28
  2. Pengfei Guo · 2 shared papers, 2020–2022 · strength 0.28
  3. Jianghua Feng · 2 shared papers, 2020–2022 · strength 0.28
  4. Heguang Huang · 1 shared paper, 2022 · strength 0.17
  5. Congfei Wang · 1 shared paper, 2020 · strength 0.11
  6. Heguang Huang · 1 shared paper, 2020 · strength 0.11
  7. Jieming Xie · 1 shared paper, 2020 · strength 0.11
  8. Minghuang Chen · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.